A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane

J A van den Hoek1, J A van de Weerd, T D Baayen

  • 1Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, the Netherlands.

Insights

Scabies outbreaks in a nursing home showed resistance to standard treatments like lindane and ivermectin. Topical permethrin cream effectively resolved persistent scabies infections, indicating its efficacy against resistant strains.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Parasitology

Background:

  • Scabies outbreaks pose significant challenges in institutional settings like nursing homes.
  • Standard treatments for scabies, including lindane and ivermectin, have shown varying efficacy.
  • Observed recurrences suggested potential drug resistance in scabies mites.

Purpose of the Study:

  • To describe a scabies outbreak in a nursing home.
  • To evaluate the effectiveness of standard scabies treatments.
  • To identify an effective treatment for drug-resistant scabies.

Main Methods:

  • Case description of a scabies outbreak in Amsterdam.
  • Administration of standard treatments (lindane, ivermectin).
  • Subsequent treatment with 5% permethrin cream.

Main Results:

  • Recurrences of scabies were noted after treatment with lindane and ivermectin.
  • A high cure rate was achieved using 5% permethrin.
  • Permethrin demonstrated effectiveness against scabies strains potentially resistant to other treatments.

Conclusions:

  • Standard scabies treatments may face challenges due to drug resistance.
  • Topical 5% permethrin is an effective treatment for scabies, even in cases of suspected resistance.
  • Successful management of scabies outbreaks requires evaluating and adapting treatment strategies.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities